Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Aug 1.

Published in final edited form as: Lung Cancer. 2012 May 6;77(2):265–271. doi: 10.1016/j.lungcan.2012.04.010

Table 2.

Cox model results of VDR mRNA and overall/disease-free survival with continuous value in lung adenocarcinoma patients

	Factor	Overall Survival		Disease-free Survival
	Factor	Hazard Ratio (95% CI)	P	Hazard Ratio (95% CI)	P
Univariate		n=100		n=98
Univariate	VDR	0.80 (0.65–0.99)	0.03^*	0.86 (0.71–1.05)	0.86^*
Multivariate		N=100		N=98
	VDR	0.73 (0.58–0.91)	0.006	0.76 (0.61–0.95)	0.01
	Age	1.09 (0.93–1.28)	0.29	1.02 (0.88–1.18)	0.82
	Sex	0.28 (0.13–0.56)	0.0004	0.36 (0.19–0.67)	0.001
	Disease stage		0.0007		<.0001
	II vs I	0.29 (0.13–0.68)		0.35 (0.17–0.75)
	III vs I	0.25 (0.11–0.55)		0.24 (0.12–0.49)
	Tumor grade		0.08		0.25
	Moderately vs Well	0.38 (0.14–0.94)		0.52 (0.23–1.13)
	Poorly vs Well	0.35 (0.12–0.87)		0.58 (0.25–1.26)

VDR: Vitamin D receptor.

^*

Likelihood ratio test.